(Q39796757)

English

Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence

scientific article published on 5 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Victor Warren Fazio

7

object named as

Victor W Fazio

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Luiz Felipe de Campos-Lobato

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Luca Stocchi

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Andre da Luz Moreira

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Daniel Geisler

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

David W Dietz

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Ian C Lavery

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Matthew F Kalady

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

5 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1590-1598

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

https://scigraph.springernature.com/pub.10.1245/s10434-010-1506-1

0 references

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Treatment of colon and rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Recurrence and survival after total mesorectal excision for rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Effective surgical adjuvant therapy for high-risk rectal carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Local recurrences after sphincter saving excisions for carcinoma of the rectum and rectosigmoid

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Genetic and molecular diversity of colon cancer hepatic metastases.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Combined-modality therapy in locally advanced primary rectal cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Chemoradiotherapy and adjuvant chemotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Revised TN categorization for colon cancer based on national survival outcomes data

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Absence of Lymph Nodes in the Resected Specimen After Radical Surgery for Distal Rectal Cancer and Neoadjuvant Chemoradiation Therapy: What does it Mean?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1506-1

21 January 2018

Identifiers

10.1245/S10434-010-1506-1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39796757&oldid=2090510621"